Literature DB >> 11720471

Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects.

S Liu1, R Semenciw, A M Ugnat, Y Mao.   

Abstract

We examined time trends in thyroid cancer incidence in Canada by age, time period and birth cohort between 1970 and 1996. Age-specific incidence rates by time period and birth cohort were calculated and age-period-cohort modelling used to estimate effects underlying the observed trends. Overall age-adjusted incidence rates of thyroid cancer doubled, from 3.3 and 1.1 per 100 000 in 1970-72 to 6.8 and 2.2 per 100 000 in 1994-96, among females and males respectively. Almost all the increase between 1970-72 and 1994-96 was due to papillary carcinoma of the thyroid. Age, birth cohort and period effects significantly improved the fit of the model for females, while age and birth cohort effects were significant determinants of the incidence among males. There were significant differences in the patterns/curvature for age, period and birth cohort effects between women and men. Our results suggest that the increases in thyroid cancer incidence in Canada may be associated with more intensive diagnostic activities and change in radiation exposure in childhood and adolescence. Temporal changes in reproductive factors among young women may explain some of the gender differences observed. Copyright 2001 Cancer Research Campaign

Entities:  

Mesh:

Year:  2001        PMID: 11720471      PMCID: PMC2375257          DOI: 10.1054/bjoc.2001.2061

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  Analysing the temporal effects of age, period and cohort.

Authors:  T R Holford
Journal:  Stat Methods Med Res       Date:  1992       Impact factor: 3.021

2.  Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period.

Authors:  L A Akslen; T Haldorsen; S O Thoresen; E Glattre
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

3.  Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type.

Authors:  B Pettersson; H O Adami; E Wilander; M P Coleman
Journal:  Int J Cancer       Date:  1991-04-22       Impact factor: 7.396

4.  Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland.

Authors:  F Levi; S Franceschi; C Gulie; E Negri; C La Vecchia
Journal:  Oncology       Date:  1993 Jul-Aug       Impact factor: 2.935

5.  Issues and epidemiological evidence regarding radiation-induced thyroid cancer.

Authors:  R E Shore
Journal:  Radiat Res       Date:  1992-07       Impact factor: 2.841

6.  Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort.

Authors:  M R Galanti; M Lambe; A Ekbom; P Sparén; B Pettersson
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

7.  Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981.

Authors:  M R Spitz; J G Sider; R L Katz; E S Pollack; G R Newell
Journal:  Int J Cancer       Date:  1988-10-15       Impact factor: 7.396

Review 8.  Thyroid cancer.

Authors:  S Franceschi; C La Vecchia
Journal:  Cancer Surv       Date:  1994

9.  Medical diagnostic x rays and thyroid cancer.

Authors:  P D Inskip; A Ekbom; M R Galanti; L Grimelius; J D Boice
Journal:  J Natl Cancer Inst       Date:  1995-11-01       Impact factor: 13.506

10.  Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution.

Authors:  I dos Santos Silva; A J Swerdlow
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more
  78 in total

1.  Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006.

Authors:  Oladejo Olaleye; Udeme Ekrikpo; Ram Moorthy; Owen Lyne; Jill Wiseberg; Myles Black; David Mitchell
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-12       Impact factor: 2.503

2.  Ultrastructural features of collagen in thyroid carcinoma tissue observed by polarization second harmonic generation microscopy.

Authors:  Danielle Tokarz; Richard Cisek; Ahmad Golaraei; Sylvia L Asa; Virginijus Barzda; Brian C Wilson
Journal:  Biomed Opt Express       Date:  2015-08-21       Impact factor: 3.732

3.  Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.

Authors:  Briseis Aschebrook-Kilfoy; Mary H Ward; Mona M Sabra; Susan S Devesa
Journal:  Thyroid       Date:  2010-12-27       Impact factor: 6.568

4.  Explaining the increasing incidence of differentiated thyroid cancer.

Authors:  Jacques How; Roger Tabah
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

5.  Impact of Dyslipidemia on the Risk of Second Cancer in Thyroid Cancer Patients: A Korean National Cohort Study.

Authors:  Joon Ho; Eunhwa Kim; Minkyung Han; Inkyung Jung; Jandee Lee; Young Suk Jo
Journal:  Ann Surg Oncol       Date:  2021-01-22       Impact factor: 5.344

6.  Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.

Authors:  Lindsey R Enewold; Jing Zhou; Susan S Devesa; Amy Berrington de Gonzalez; William F Anderson; Shelia H Zahm; Alexander Stojadinovic; George E Peoples; Aizenhawar J Marrogi; John F Potter; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-13       Impact factor: 4.254

7.  MiR-574-5p mediates the cell cycle and apoptosis in thyroid cancer cells via Wnt/β-catenin signaling by repressing the expression of Quaking proteins.

Authors:  Zhejia Zhang; Xinying Li; Qian Xiao; Zhiming Wang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

8.  MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

Authors:  Guo-Qing Sui; Dan Fei; Feng Guo; Xi Zhen; Qiang Luo; Shuai Yin; Hui Wang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.

Authors:  Bo Youn Cho; Hoon Sung Choi; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; Kyung Won Kim; Ka Hee Yi; June-Key Chung; Yeo-Kyu Youn; Nam Han Cho; Do Joon Park; Chang-Soon Koh
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

10.  Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.

Authors:  Anna M Sawka; Sharon Straus; James D Brierley; Richard W Tsang; Lorne Rotstein; Gary Rodin; Amiram Gafni; Shereen Ezzat; Lehana Thabane; Kevin E Thorpe; David P Goldstein
Journal:  Trials       Date:  2010-07-26       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.